Cargando…
Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency
Parkinson’s disease (PD) is the second-most common neurodegenerative disorder, whose physiopathology is still unclear. Moreover, there is an urgent need to discover new biomarkers and therapeutic targets to facilitate its diagnosis and treatment. Previous studies performed in PD models and samples f...
Autores principales: | Solana-Manrique, Cristina, Sanz, Francisco José, Torregrosa, Isabel, Palomino-Schätzlein, Martina, Hernández-Oliver, Carolina, Pineda-Lucena, Antonio, Paricio, Nuria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834223/ https://www.ncbi.nlm.nih.gov/pubmed/35159141 http://dx.doi.org/10.3390/cells11030331 |
Ejemplares similares
-
Disease-Modifying
Effects of Vincamine Supplementation
in Drosophila and Human Cell Models
of Parkinson’s Disease Based on DJ-1 Deficiency
por: Sanz, Francisco José, et al.
Publicado: (2023) -
A High-Throughput Chemical Screen in DJ-1β Mutant Flies Identifies Zaprinast as a Potential Parkinson’s Disease Treatment
por: Sanz, Francisco José, et al.
Publicado: (2021) -
Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases
por: Solana-Manrique, Cristina, et al.
Publicado: (2022) -
Mild Muscle Mitochondrial Fusion Distress Extends Drosophila Lifespan through an Early and Systemic Metabolome Reorganization
por: Tapia, Andrea, et al.
Publicado: (2021) -
Drosophila Models of Parkinson's Disease: Discovering Relevant Pathways and Novel Therapeutic Strategies
por: Muñoz-Soriano, Verónica, et al.
Publicado: (2011)